News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Earnings (World)
NeuroDerm Ltd. (NDRM) Announces Third Quarter 2014 Financial Results And Provides A Corporate Update 12/18/2014
Origin Agritech Limited (SEED) To Announce Fiscal 2014 Annual Financial Results On January 8th, 2015 12/15/2014
Abzena PLC Release: Interim Results For The Six Months Ended 30 September 2014 12/11/2014
Tianyin Pharmaceutical Co, Inc. Reports Fiscal Year 2014 Financial Results 12/11/2014
Scancell Holdings Plc Interim Results For The Six Months Ended 31 October 2014 12/10/2014
Consort Medical Interim Results For The Six Months Ended 31 October 2014 12/4/2014
GW Pharmaceuticals plc Reports 2014 Q4 And Full Year Financial Results 12/2/2014
uniQure Announces Results For The Third Quarter Of 2014 12/1/2014
iCo Therapeutics Inc. Announces Third Quarter 2014 Financial Results And Corporate Update 12/1/2014
Antibe Therapeutics Inc. Reports Q2 2015 Interim Financial And Operating Results 12/1/2014
XTL Biopharmaceuticals Ltd. (XTLB) Provides Financial and Operational Update For the Third Quarter of 2014 12/1/2014
China Cord Blood Corporation Reports Financial Results For The Second Quarter And First Half Of Fiscal 2015 11/26/2014
ProQR Therapeutics B.V. (PRQR) Announces Results For The Third Quarter Of 2014 11/24/2014
Bio Blast Pharma Reports Third Quarter Financial Results 11/21/2014
Medivir AB (MVRBF): Interim Report, January – September 2014 11/20/2014
Mallinckrodt plc Reports Fiscal 2014 Fourth Quarter And Fiscal 2014 Financial Results 11/19/2014
China Cord Blood Corporation To Report Second Quarter And First Half Of Fiscal 2015 Financial Results 11/18/2014
Affimed Reports Financial Results For Third Quarter 2014 11/18/2014
Cardio3 BioSciences Announces Q3 2014 Business Update 11/18/2014
ConvaTec Announces 2014 Third Quarter Earnings Call 11/17/2014
Sinovac Biotech Ltd. (SVA) Reports Unaudited Third Quarter Financial Results 11/17/2014
ProSensa Holding N.V. (RNA) Announces 3rd Quarter 2014 Financial Results And Recent Corporate Developments 11/17/2014
WuXi PharmaTech Co., Ltd. Reports Record Revenues, CapEx Spending 11/17/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Reports Financial Results For Third Quarter And Nine Months Ended September 30, 2014 11/14/2014
China Pharma Holdings, Inc. (CPHI.OB) Reports Third Quarter 2014 Financial Results 11/14/2014
Biostar Pharmaceuticals, Inc. (BSPM) Announces Third Quarter 2014 Financial Results 11/14/2014
ALK-Abello A/S Release: Nine-Month Interim Report (Q3) 2014 11/14/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January – September 2014 11/14/2014
WuXi PharmaTech Co., Ltd. Announces Third-Quarter 2014 Results 11/13/2014
BrainStorm Cell Therapeutics Inc. Announces Financial Results For The Third Quarter Of 2014 And Provides Corporate Update 11/13/2014
Ablynx (ABLYF) Announces Its Business Update For The First Nine Months Of 2014 11/13/2014
Enzymotec Reports Third Quarter 2014 Unaudited Financial Results 11/13/2014
Innocoll, Inc. (INNL) Announces Third Quarter 2014 Financial and Operating Results 11/13/2014
Sophiris Bio Inc. (SPHS) Reports Third Quarter Financial Results 11/13/2014
Sangui BioTech International Inc. (SGBI): Revenues Improved In The First Quarter Of The 2015 Financial Year 11/13/2014
Galmed Pharmaceuticals Provides Business Update And Reports Year-To-Date 2014 Financial Results 11/12/2014
Evotec AG (EVTG.F) Reports Results Of The First Nine Months Of 2014 11/12/2014
Kamada Ltd. (KMDA) Announces Third Quarter 2014 Financial Results 11/12/2014
Veloxis Pharmaceuticals A/S (VELO) Announces Financial Results For The First Nine Months Of 2014 And Improves The Full Year Outlook 11/12/2014
Affimed Therapeutics AG (AFMD) Announces Third Quarter 2014 Financial Results Conference Call 11/11/2014
SYGNIS Reports Nine-Month Results For The Period Ended 30 September 2014 And Announces New Product And Commercialisation Strategy 11/11/2014
Release Date Of Nine-Month Interim Report (Q3) 2014 For ALK-Abello A/S 11/10/2014
RedHill Biopharma Ltd. (RDHL) Reports Results For The Third Quarter Of 2014 11/10/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Third Quarter 2014 Conference Call & Webcast Scheduled For Monday, November 17, 2014 11/10/2014
BioLineRx Ltd. Reports Third Quarter 2014 Financial Results 11/10/2014
Kamada Ltd. (KMDA) To Host Third Quarter 2014 Financial Results Conference Call On November 12, 2014 11/10/2014
Cardiome Pharma Corp. (COM.TO) Reports Third Quarter 2014 Financial Results 11/7/2014
Innocoll, Inc. (INNL) To Report Third Quarter 2014 Financial Results And Host Webcast And Conference Call On November 13, 2014 11/7/2014
Recipharm AB: Interim Report January-September 2014 11/7/2014
Horizon Pharma plc.  (HZNP) Reports Third Quarter 2014 Financial Results And Raises Guidance For 2014 And 2015 11/7/2014
China Biologic Products Reports Financial Results For The Third Quarter And First Nine Months Of 2014 11/6/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Third Quarter 2014 Results 11/6/2014
BRASKEM Announces 3Q14 Results 11/6/2014
MediWound (MDWD) Reports Third Quarter 2014 Financial Results 11/6/2014
MEDA: Interim Report, January-September 2014 11/6/2014
PhotoCure: Results For Third Quarter And The First Nine Months 2014 11/6/2014
Hikma Pharmaceuticals (HIK.L) Release: Interim Management Statement 11/6/2014
Alcobra (ADHD) To Release Third Quarter 2014 Financial Results And Host Corporate Update Conference Call And Webcast On Monday, November 17 11/6/2014
Onxeo: Quarterly Information As Of September 30, 2014 11/6/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Third Quarter 2014 Financial Results And Updated Guidance 11/5/2014
AEterna Zentaris (AEZS) Reports Third Quarter 2014 Financial And Operating Results 11/5/2014
Evotec AG (EVTG.F) To Report Results For The First Nine Months Of 2014 On 12 November 2014 11/5/2014
Sinovac Biotech Ltd. (SVA) To Host Conference Call To Report Third Quarter 2014 Unaudited Financial Results 11/5/2014
Actavis (ACT) Net Revenue Increases 83% To $3.7 Billion In Third Quarter 2014; Non-GAAP EPS Increases 53% To $3.19 11/5/2014
Endo Pharmaceuticals (ENDP) Reports Third Quarter Financial Results 11/5/2014
China Pharma Holdings, Inc. (CPHI.OB) To Hold Third Quarter 2014 Earnings Conference Call On Friday November 14, 2014 At 8:30 A.M. ET 11/5/2014
BrainStorm Cell Therapeutics Inc. To Report Third Quarter 2014 Financial Results On Thursday, November 13 11/5/2014
Foundation Medicine, Inc. (FMI) Announces 2014 Third Quarter Results and Recent Highlights 11/5/2014
Macrocure (MCUR) Announces Third Quarter 2014 Financial Results 11/4/2014
Prothena Corporation plc Reports Third Quarter 2014 Financial Results And R&D Progress 11/4/2014
Resverlogix Corporation (RVX.TO) Names Michael Sweeney, M.D., As Senior Vice President Of Clinical Development 11/4/2014
TxCell Reports Revenues For The Third Quarter Of 2014 11/4/2014
BioLineRx Ltd. To Report Third Quarter 2014 Results On November 10, 2014 11/3/2014
BioTie Therapies Corp. Interim Report 1 January - 30 September 2014 10/31/2014
Lonza Group Ltd. (LZAGY.PK)’s Overall Business Performance Year-to-Date On Track 10/31/2014
Enzymotec To Report Third Quarter Fiscal Year 2014 Financial Results 10/30/2014
China Biologic Products To Report Third Quarter 2014 Financial Results 10/30/2014
Aptose Biosciences To Host Conference Call And Webcast For Four Month Interim Period Ended September 30, 2014 10/30/2014
Biotage AB (BIOTa.ST): Interim Report For The Period January - September 2014 10/30/2014
Teva Pharmaceutical Industries Limited (TEVA) Reports Third Quarter 2014 Results 10/30/2014
PHT Corporation Achieves Strong Growth In 3rd Quarter As Demand For Patient-Driven eData Systems In Clinical Research Grows 10/30/2014
Beximco Pharmaceuticals Release: Financial Results For The Third Quarter Of 2014 10/30/2014
Swedish Orphan Biovitrum Publishes Report For The Third Quarter 2014 10/30/2014
Pharming Group (PHGUF.PK) Reports On Financial Results For The First Nine Months Of 2014 10/30/2014
Neuland Labs Reports Second Quarter Fiscal Year 2015 Financial Results 10/29/2014
Ipsen (IPN.PA): Sales In The 3rd Quarter And First Nine Months Of 2014 10/29/2014
TRANSGENE (ENX:TNG) Announces Events Calendar For Fourth Quarter 2014 10/29/2014
Alkermes plc (ALKS) Reports Third Quarter 2014 Financial Results 10/29/2014
MediWound (MDWD) To Host Third Quarter 2014 Financial Results Conference Call On November 5, 2014 At 4:30 P.M. Eastern Time 10/29/2014
Compugen Ltd. (CGEN) Reports Third Quarter 2014 Financial Results 10/29/2014
Karo Bio AB: Interim Report January-September 2014 10/29/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Q2 And H1 FY15 Financial Results 10/29/2014
AEterna Zentaris (AEZS) To Announce Third Quarter 2014 Financial And Operating Results On November 4, 2014 10/28/2014
IMRIS Reports Third-Quarter 2014 Financial Results 10/28/2014
Sanofi (SAN.PA) Q3 2014 Results - Interview With Jérôme Contamine 10/28/2014
Nolato: Strong Earnings And High Margin 10/28/2014
Oxford Immunotec Limited (OXFD) Schedules Third Quarter 2014 Earnings Release and Conference Call For November 4, 2014 10/24/2014
Shire’s Clear And Focused Strategy Delivers Record Quarterly Revenues. Non GAAP Diluted Earnings Per ADS Up 60%. 10/24/2014
Perrigo Company (PRGO) To Release First Quarter Fiscal Year 2015 Results On November 6, 2014 10/23/2014
Flamel Technologies (FLML) To Report Third Quarter Of Fiscal Year 2014 Results 10/23/2014
Alkermes plc (ALKS) To Host Conference Call To Discuss Third Quarter 2014 Financial Results 10/23/2014
BioInvent (BOVNF) Interim Report 1 January – 30 September 2014 10/23/2014
Novozymes A/S (NVZMY) Increases Expectations For Full-Year Profit After Strong Q3 10/23/2014
Trinity Biotech (TRIB) Temporary Suspends Meritas Troponin Trials 10/23/2014
ICON Reports Third Quarter 2014 And Increases Earnings Guidance 10/22/2014
Macrocure (MCUR) Announces Third Quarter 2014 Financial Results Date And Conference Call 10/21/2014
WuXi PharmaTech Co., Ltd. Schedules Third-Quarter 2014 Earnings Release 10/21/2014
CARMAT: 2014 Half-Year Results 10/21/2014
Karolinska Development AB (publ) – Interim Report January – September 2014 10/21/2014
Dr. Reddy's Laboratories Ltd. (RDY)'s to Release Q2 FY15 Results On October 29, 2014 10/17/2014
Getinge Group Interim Report January – September 2014 10/16/2014
Medgenics, Inc. Reports Positive Initial Clinical Data And Third Quarter Financial Results 10/15/2014
Mallinckrodt plc Provides Fiscal Year 2015 Financial Guidance 10/14/2014
Acasti Pharma Announces Second Quarter Results 10/14/2014
MEDIAN Technologies Release: 2014 First Half Results In Line With Expectations 10/9/2014
Gerresheimer Increases Third-Quarter Revenues 10/8/2014
Teva Pharmaceutical Industries Limited (TEVA) To Report Third Quarter 2014 Financial Results On October 30, 2014 10/7/2014
Sangui Biotech Yields Revenues Of Over USD70,000 In Q1 2015 According To Preliminary Figures 10/7/2014
Trinity Biotech (TRIB) To Announce Third Quarter Fiscal 2014 Financial Results 10/6/2014
Genetic Technologies Limited (GTG.AX) Announces Quarterly BREVAGen(TM) Results 10/6/2014
Getinge Announces Date Of 2014 Q3 Report And Conference Call 10/1/2014
Actavis (ACT) To Host Third Quarter 2014 Earnings Conference Call And Webcast 9/30/2014
Bioniche Life Sciences Inc. (BNC) Reports Fiscal 2014 Year-End Results 9/29/2014
Sangui BioTech International Inc. (SGBI): Revenues Attain USD 133,000 in Financial Year 2014 9/25/2014
Synairgen plc Interim Results For The Six Months Ended 30 June 2014 9/25/2014
Valeant Pharmaceuticals International (VRX) Provides Update On Third Quarter Results And Sends Letter To Allergan Inc. (AGN) CEO And Lead Independent Director 9/24/2014
TxCell Financial Results For The First Half Of 2014 9/24/2014
Neovacs SA Release: 2014 Half-Year Results 9/18/2014
Cegedim SA: Release Of Its 2014 Half-Year Financial Report 9/18/2014
Innate Pharma (IPH.PA ): First Half Of 2014: Broadened Clinical Portfolio And Strengthened Cash Position 9/17/2014
Newron Pharmaceuticals (NWRN) Reports Half-Year Results 2014 9/16/2014
Auris Medical AG (EARS) Reports Second Quarter 2014 Financial Results and Provides Business Update 9/15/2014
Verona Pharma (VRP.L) Release: Interim Results For The Six Months Ended 30 June 2014 9/11/2014
Scancell Release: Final Results For The Year Ended 30 April 2014 9/4/2014
XTL Biopharmaceuticals Ltd. (XTLB) Provides Financial And Operational Update For The Second Quarter of 2014 9/3/2014
uniQure Announces Results For The Second Quarter And First Half Of 2014 And Provides Update On Gene Therapy Programs 9/2/2014
ERYtech Pharma Business Update And Financial Results For The First Half Of 2014 9/2/2014
BioBlast Pharma (ORPN) Reports Second Quarter Financial Results 8/29/2014
China Cord Blood Corporation Reports First Quarter Fiscal 2015 Financial Results 8/29/2014
Ablynx (ABLYF) Announces Half-Year Results For 2014 8/28/2014
Bavarian Nordic (BAVA.CO) Announces First Half 2014 Results 8/28/2014
QRxPharma Ltd. (QRXPY): ASX Preliminary Final Report – 2014 Financial Year 8/28/2014
With Revenues From Diabetes And Cardiovascular Portfolio At Risk, Analysts Remain Cautious About Sanofi India 8/27/2014
Macrocure (MCUR) Announces Second Quarter 2014 Financial Results 8/27/2014
Amarantus BioSciences, Inc. Reports Second Quarter 2014 Financial Results, Announces Business Update Call 8/27/2014
Sihuan Pharmaceutical Holdings Group Ltd. Announces 2014 Interim Results 8/27/2014
PhotoCure: Results For Second Quarter And The First Half Year 2014 8/26/2014
Ablynx (ABLYF) Will Announce Its Half-Year Results For 2014 With Webcast 8/21/2014
Veloxis Pharmaceuticals A/S (VELO) Announces Financial Results For The First Six Months Of 2014 8/21/2014
China Cord Blood Corporation To Report First Quarter Of Fiscal 2015 Financial Results 8/21/2014
Medivir AB (MVRBF): Interim Report, January – June 2014* 8/21/2014
DiaGenic ASA: Q2 2014 - Financial Report 8/21/2014
Karolinska Development AB (publ) – Interim Report January – June 2014 8/21/2014
MDxHealth, Inc. (MXDHF) Reports First Half Year 2014 Results 8/21/2014
TiGenix: Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 8 September 2014 8/21/2014
NeuroVive Pharmaceutical AB: Interim Report 1 Jan. 2014 To 30 Jun. 2014 8/20/2014
Hikma Pharmaceuticals Delivers Excellent First Half Results With 16% Revenue Growth And 44% Increase In Adjusted EPS 8/20/2014
Source BioScience Release: Half Year Report For The Six Months Ended 30 June 2014 8/20/2014
Probi: Highest-Ever Net Sales For A Single Quarter 8/19/2014
Notice Of Zealand Pharma  (ZEAL.CO)'s Interim Report For H1 2014 And Related Conference Call 8/18/2014
Sinovac Biotech Ltd. (SVA) Reports Unaudited Second Quarter Financial Results 8/15/2014
Yew Bio-Pharm Group Reports 2014 Second Quarter Financial Results 8/15/2014
China Pharma Holdings, Inc. (CPHI.OB) Reports Second Quarter 2014 Financial Results 8/15/2014
Perrigo Company (PRGO) Announces Quarterly Dividend 8/14/2014
Kamada Ltd. (KMDA) Reports Second Quarter Financial Results 8/14/2014
WuXi PharmaTech Co., Ltd. Announces Second-Quarter 2014 Results 8/14/2014
Biotage AB (BIOTa.ST): Interim Report For The Period January – June 2014 8/14/2014
Recipharm AB: Interim Report January-June 2014 8/14/2014
Concord Medical Services Holdings Limited (CCM) Reports Second Quarter 2014 Financial Results 8/14/2014
Perrigo Company (PRGO) Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins 8/14/2014
Biostar Pharmaceuticals, Inc. (BSPM) Announces Second Quarter 2014 Financial Results 8/14/2014
SYGNIS Pharma AG Reports Half-Year Results For The Period Ended June 30, 2014 8/14/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January - June 2014 8/13/2014
Evotec AG (EVTG.F) Reports Results Of First Half Of 2014 8/12/2014
Epigenomics AG Announces H1 2014 And Q2 2014 Financial Results And Reports On Operational Highlights 8/12/2014
Alcobra (ADHD) Announces Second Quarter Financial Results And Provides Corporate Update 8/11/2014
Invitation To Presentation Of Recipharm AB’s Interim Report For The Second Quarter Of 2014 On August 14th 8/11/2014
AEterna Zentaris (AEZS) Reports Second Quarter 2014 Financial And Operating Results 8/8/2014
PuriCore Release: 2014 Interim Financial Results 8/8/2014
MediGene AG (MDGEF.PK) Significantly Improves Financial Results For The First Six Months Of 2014 8/7/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Second Quarter 2014 Results 8/7/2014
GW Pharmaceuticals Reports 2014 Third Quarter Financial Results 8/6/2014
China Biologic Products Reports Financial Results For The Second Quarter Of 2014 8/6/2014
Compugen Ltd. (CGEN) Reports 2nd Quarter 2014 Financial Results 8/6/2014
China Pharma Holdings, Inc. (CPHI.OB) To Hold Second Quarter 2014 Earnings Conference Call On Friday August 15, 2014 At 8:30 A.M. ET 8/5/2014
Enzymotec Reports Second Quarter 2014 Unaudited Financial Results 8/5/2014
Novo Nordisk A/S (NVO) Leapfrogs GlaxoSmithKline (GSK) To Take Spot As Europe's Fourth Largest Drugmaker By Market Value 8/5/2014
ProSensa Holding N.V. (RNA) To Webcast Conference Call Discussing 2nd Quarter 2014 Financial Results And Corporate Update On August 12, 2014 8/4/2014
Prothena Corporation plc Reports Second Quarter 2014 Financial Results And R&D Progress 8/4/2014
AstraZeneca PLC (AZN) Touts 2nd Quarter Results After Fending Off Pfizer Inc. (PFE), CEO And Investors Rejoice 8/1/2014
Alcobra (ADHD) To Release Second Quarter 2014 Results And Host Investor Conference Call And Webcast On Monday, August 11 8/1/2014
Sanofi (France) (SAN.PA) Second Quarter Profit Jumps 73 Percent; Earnings Outlook Lifted 7/31/2014
Nuvo Research Inc. (NRI.TO) Announces 2014 Second Quarter Results 7/31/2014
Valeant Pharmaceuticals International (VRX) Reports Second Quarter 2014 Financial Results 7/31/2014
Endo Pharmaceuticals (ENDP) Reports Second Quarter Financial Results 7/31/2014
Alkermes plc (ALKS) Reports Second Quarter 2014 Financial Results 7/31/2014
Teva Pharmaceutical Industries Limited (TEVA) Reports Second Quarter 2014 Results 7/31/2014
Guerbet (GBT): 2014 First-Half Results 7/30/2014
IMRIS To Hold Second Quarter 2014 Results Conference Call 7/30/2014
GW Pharmaceuticals To Report Q3 2014 Financial Results And Host Conference Call On 6 August, 2014 7/30/2014



//-->